OrthoPediatrics Corp. (KIDS)

In the past six months, OrthoPediatrics Corp. has experienced stock fluctuations. As of December 17, 2025, the share price was $17.32, a 22.44% decline from December 18, 2024. There was an 8.00% increase on January 8, 2026, after announcing record preliminary 2025 revenue and strong 2026 guidance. Shares closed up 3.14% on January 6, 2026, after the company promoted its GIRO™ Growth Modulation System. Conversely, on January 7, 2026, shares closed down 1.87%. In October 2025, preliminary Q3 2025 net revenue fell short of the company's forecast, and Needham lowered its price target to $26.00 from $42.00 in January 2026.

Demand for OrthoPediatrics Corp. products and services exhibits some seasonality, with the summer months typically being high months for pediatric orthopedic procedures due to children being out of school.

OrthoPediatrics Corp. is a global medical device company focused on addressing the orthopedic needs of children. Founded in 2006, it designs, develops, manufactures, and markets implants, instruments, and specialized braces for children with orthopedic conditions. The company operates within the pediatric orthopedic segment and has a comprehensive product portfolio serving trauma and deformity, scoliosis, and sports medicine/other procedures.

OrthoPediatrics Corp. has a global presence, distributing its products in the United States and over 75 countries internationally. The company operates over 40 clinics worldwide, a significant increase from 26 clinics acquired with Boston O&P in January 2024. Its global sales organization is exclusively focused on pediatric orthopedics.

OrthoPediatrics maintains a strong reputation as a company focused on advancing pediatric orthopedics and improving the lives of children with orthopedic conditions. Its dedication to research and development and strong relationships with surgeons have fueled its growth. The company has a consensus recommendation of "Moderate Buy" from ten brokerages. Recent events, such as record revenue, EUMDR certification, and the launch of innovative products, contribute to a positive brand image.

OrthoPediatrics Corp. has significant institutional ownership, with 270 institutional owners and shareholders holding 20,197,815 shares. Major institutional shareholders include Brown Advisory Inc, BlackRock, Inc., and Morgan Stanley. David R. Pelizzon is the largest individual shareholder, owning 55.18% of the company, and Squadron Capital LLC is also a major owner.